Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77


Stability of miR-126 in Urine and Its Potential as a Biomarker for Renal Endothelial Injury with Diabetic Nephropathy.

Liu Y, Gao G, Yang C, Zhou K, Shen B, Liang H, Jiang X.

Int J Endocrinol. 2014;2014:393109. doi: 10.1155/2014/393109. Epub 2014 Apr 17.


Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker.

Al-Kafaji G, Al-Mahroos G, Al-Muhtaresh HA, Skrypnyk C, Sabry MA, Ramadan AR.

Exp Ther Med. 2016 Aug;12(2):815-822. Epub 2016 May 26.


miRNAs in Urine Extracellular Vesicles as Predictors of Early-Stage Diabetic Nephropathy.

Jia Y, Guan M, Zheng Z, Zhang Q, Tang C, Xu W, Xiao Z, Wang L, Xue Y.

J Diabetes Res. 2016;2016:7932765. doi: 10.1155/2016/7932765. Epub 2016 Jan 28.


The effects of diabetes mellitus and diabetic nephropathy on bone and mineral metabolism in T2DM patients.

Chen H, Li X, Yue R, Ren X, Zhang X, Ni A.

Diabetes Res Clin Pract. 2013 May;100(2):272-6. doi: 10.1016/j.diabres.2013.03.007. Epub 2013 Mar 21.


Measurement of urinary TGF-β1 in patients with diabetes mellitus and normal controls.

Tsapenko MV, Nwoko RE, Borland TM, Voskoboev NV, Pflueger A, Rule AD, Lieske JC.

Clin Biochem. 2013 Oct;46(15):1430-5. doi: 10.1016/j.clinbiochem.2013.05.041. Epub 2013 May 16.


Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.

Jiang H, Guan G, Zhang R, Liu G, Cheng J, Hou X, Cui Y.

Diabetes Metab Res Rev. 2009 Mar;25(3):232-41. doi: 10.1002/dmrr.940.


Stability of miRNA in human urine supports its biomarker potential.

Mall C, Rocke DM, Durbin-Johnson B, Weiss RH.

Biomark Med. 2013 Aug;7(4):623-31. doi: 10.2217/bmm.13.44.


Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus.

Zhuo L, Zou G, Li W, Lu J, Ren W.

Eur J Med Res. 2013 Feb 22;18:4. doi: 10.1186/2047-783X-18-4.


Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy.

Zheng M, Lv LL, Ni J, Ni HF, Li Q, Ma KL, Liu BC.

PLoS One. 2011;6(5):e20431. doi: 10.1371/journal.pone.0020431. Epub 2011 May 31.


Elevated urinary level of vitamin D-binding protein as a novel biomarker for diabetic nephropathy.

Tian XQ, Zhao LM, Ge JP, Zhang Y, Xu YC.

Exp Ther Med. 2014 Feb;7(2):411-416. Epub 2013 Nov 26.


Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy.

Ezzidi I, Mtiraoui N, Mohamed MB, Mahjoub T, Kacem M, Almawi WY.

J Diabetes Complications. 2008 Sep-Oct;22(5):331-8. doi: 10.1016/j.jdiacomp.2007.11.011. Epub 2008 Apr 16.


Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.

Zhu C, Liang QL, Hu P, Wang YM, Luo GA.

Talanta. 2011 Sep 30;85(4):1711-20. doi: 10.1016/j.talanta.2011.05.036. Epub 2011 Jun 15.


Increased urinary excretion of orosomucoid is a risk predictor of diabetic nephropathy.

Jiang H, Guan G, Zhang R, Liu G, Liu H, Hou X, Cheng J.

Nephrology (Carlton). 2009 Apr;14(3):332-7. doi: 10.1111/j.1440-1797.2008.01053.x. Epub 2009 Jan 8.


Wilm's tumor-1 protein levels in urinary exosomes from diabetic patients with or without proteinuria.

Kalani A, Mohan A, Godbole MM, Bhatia E, Gupta A, Sharma RK, Tiwari S.

PLoS One. 2013;8(3):e60177. doi: 10.1371/journal.pone.0060177. Epub 2013 Mar 27.


Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.

Eissa S, Matboli M, Bekhet MM.

Biomed Pharmacother. 2016 Jun 23;83:92-99. doi: 10.1016/j.biopha.2016.06.018. [Epub ahead of print]


A potentially functional polymorphism in the regulatory region of let-7a-2 is associated with an increased risk for diabetic nephropathy.

Zhou J, Peng R, Li T, Luo X, Peng H, Zha H, Yin P, Wen L, Zhang Z.

Gene. 2013 Sep 25;527(2):456-61. doi: 10.1016/j.gene.2013.06.088. Epub 2013 Jul 13.


Serum miR-21 may be a Potential Diagnostic Biomarker for Diabetic Nephropathy.

Wang J, Duan L, Tian L, Liu J, Wang S, Gao Y, Yang J.

Exp Clin Endocrinol Diabetes. 2016 Jul;124(7):417-23. doi: 10.1055/s-0035-1565095. Epub 2015 Nov 17.


Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells.

Satirapoj B, Wang Y, Chamberlin MP, Dai T, LaPage J, Phillips L, Nast CC, Adler SG.

Nephrol Dial Transplant. 2012 Jul;27(7):2702-11. doi: 10.1093/ndt/gfr670. Epub 2011 Dec 13.


Diagnostic value of the combined measurement of serum hcy, serum cys C, and urinary microalbumin in type 2 diabetes mellitus with early complicating diabetic nephropathy.

Wang T, Wang Q, Wang Z, Xiao Z, Liu L.

ISRN Endocrinol. 2013 Sep 18;2013:407452. doi: 10.1155/2013/407452. eCollection 2013.

Items per page

Supplemental Content

Support Center